AF ablation Penn experience. Optimal approach to the ablation of PAF: Importance of identifying triggers 9/25/2009

Similar documents
AF ABLATION Concepts and Techniques

CLINICAL OUTCOME OF AF ABLATION Who Benefits from Catheter Ablation?? Dr Gamal Shaban MD FESC Fellow of EHRA ECR AFA AFIB ALLIANCE NHI

Atrial Fibrillation: Classification and Electrophysiology. Saverio Iacopino, MD, FACC, FESC

Mapping techniques in AFib. Helmut Pürerfellner, MD Public Hospital Elisabethinen Academic Teaching Hospital Linz, Austria

ABLATION TECHNIQUES FOR ATRIAL FIBRILLATION

Electrical isolation of the pulmonary veins (PVs) to treat

Fibrillation Atriale Paroxystique : ablation, résultats, complications

Hybrid Ablation of AF in the Operating Room: Is There a Need? MAZE III Procedure. Spectrum of Atrial Fibrillation

CATHETER ABLATION FOR ATRIAL FIBRILLATION WHEN and HOW

Debate-STAR AF 2 study. PVI is not enough

Atrial Fibrillation: Catheter Ablation with New Technologies, Improving Quality of Life and Outcomes in Various Disease States

Linear Ablation Should Not Be a Standard Part of Ablation in Persistent AF. Disclosures. LA Ablation vs. Segmental Ostial Ablation With PVI for PAF

Integration of CT and fluoroscopy images in the ablative treatment of atrial fibrillation


LONG RP TACHYCARDIA MAPPING AND RF ABLATION

Ablation of persistent AF Is it different than paroxysmal?

Catheter Ablation of Atrial Fibrillation

Ablation Should Not Be Used as Primary Therapy for Treatment of Patients with Atrial Fibrillation

PRIMARY RESULTS OF RF CATHETER ABLATION FOR AF IN VIETNAM HEART INSTITUTE. PHAM QUOC KHANH, MD, PhD. et al Vietnam Heart Institute

Catheter Ablation of Atrial Fibrillation in Patients with Prosthetic Mitral Valve

The characteristic anatomic distribution for focal atrial

Long Standing Persistent AF ; CPVI is enough for it

INTRODUCTION. Key Words:

Catheter ablation of AF Where do we stand, where do we go?

Catheter Ablation for Atrial Fibrillation: Patient Selection and Outcomes

Indicatie voor ablatie bij voorkamerfibrillatie. Andrea Sarkozy Cardiologie Universitair Ziekenhuis Antwerpen

ESSA HEART AND VASCULAR INSTITUTE APR/MAY/JUNE 2009 CLINICAL LETTER

Arrhythmia/Electrophysiology

Role of LAA isolation in AF cure

Is cardioversion old hat? What is new in interventional treatment of AF symptoms?

Storia dell ablazione della fibrillazione atriale: da dove siamo partiti, dove siamo, dove andremo. Prof. Fiorenzo Gaita

Ablation Index : A new standard for Safety and Efficacy. Dr Franck Halimi Hôpital Privé Parly 2 Le Chesnay, France

Electrophysiological Characteristics of Atrial Tachycardia After Pulmonary Vein Isolation of Atrial Fibrillation

Atrial Fibrillation Procedures Data Summary. Participant STS Period Ending 12/31/2016

Stand alone maze: when and how?

What is an O.R. Report? BY STEVE S. RYAN, PhD

Atrial Fibrillation: Electrophysiological Mechanisms and the Results of Interventional Therapy

2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation

Atrial Fibrillation 2009

Individualised strategy approach to AF ablation

Topographic Distribution of Focal Left Atrial Tachycardias Defined by Electrocardiographic and Electrophysiological Data

Balloon and Mesh Catheter Ablation of Pulmonary Veins

Repeat procedures: the best approach

Catheter Ablation of Supraventricular Arrhythmias: State of the Art

AF Ablation in 2015 Why, Who, What and How? Steve Wilton ACC Rockies, Banff March 10, 2015

Comparative Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation Executive Summary

1995 Our First AF Ablation. Atrial Tachycardias During and After Atrial Fibrillation Ablation. Left Atrial Flutter. 13 Hours Later 9/25/2009

Complications During Cardiovascular Interventions: Management and Prevention

Intracardiac EchoCardiography (ICE) Common Views

Catheter ablation of atrial fibrillation: Indications and tools for improvement of the success rate of the method. Konstantinos P.

Case 1 Left Atrial Tachycardia

What s new in my specialty?

Original Article Short- and long-term experience in pulmonary vein segmental ostial ablation for paroxysmal atrial fibrillation*

Should hybrid ablation be the standard of care instead of transcatheter ablation techniques?

A New Approach for Catheter Ablation of Atrial Fibrillation: Mapping of the Electrophysiologic Substrate

Time to recurrence of atrial fibrillation influences outcome following catheter ablation

AF Today: W. For the majority of patients with atrial. are the Options? Chris Case

PARA-HISSIAN CONCEALED ACCESSORY PATHWAY

Catheter Ablation for Persistent Atrial Fibrillation

The Who, What, Why, and How-To Guide for Circumferential Pulmonary Vein Ablation

Incidence and Disease Burden. Role of Catheter ablation Outcomes Data

Catheter ablation in AF patients with heart failure. What is possible?

PVI and What Else for Persistent AF Lessons Learned from STAR AF 2 CCCEP 2015 October 31, New York

A Cryo Anatomical Procedure to Everyone? Saverio Iacopino, FACC, FESC

Since pulmonary veins (PVs) have

Ablazione della fibrillazione atriale: dubbi presenti e prospettive future

Long-Term Outcome and Risks of Catheter Ablation for Atrial Fibrillation

Case Report Successful Multi-chamber Catheter Ablation of Persistent Atrial Fibrillation in Cor Triatriatum Sinister

The EP Perspective: Should We Do Hybrid Ablation, and Who Should We Do It On?

The radial procedure was developed as an outgrowth

Atrial Fibrillation and Sleep Apnea. Farhat S. Khairallah, MD, FHRS, FACC

Contemporary Strategies for Catheter Ablation of Atrial Fibrillation

The major thoracic veins, with their specific electrical

Peri-Mitral Atrial Flutter with Partial Conduction Block between Left Atrium and Coronary Sinus

Κατάλυση παροξυσμικής κολπικής μαρμαρυγής Ποια τεχνολογία και σε ποιους ασθενείς; Χάρης Κοσσυβάκης Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ.

Electrogram-Guided Ablation

Salt Lake Regional Medical Center, Cardiology. Terron Arbon, Stacy Tukuafu, Dean Porcelli, Paul Allred

Catheter Ablation of Atrial Fibrillation

Atrial fibrillation (AF), the most sustained cardiac arrhythmia

Cardiology Department, Ain Shams University, Cairo, Egypt.

Surgical Ablation: Which Lesion Set for Which Patient?

20% 10/9/2018. Fluoroless Ablation relinquishing an old habit. Prevalence of Atrial Fibrillation. Atrial Fibrillation is a Progressive Disease

Pulmonary vein isolation (PVI) is

Recent studies have demonstrated that pulmonary vein

AF :RHYTHM CONTROL BY DR-MOHAMMED SALAH ASSISSTANT LECTURER CARDIOLOGY DEPARTMENT

Clinical Value of Noninducibility by High-Dose Isoproterenol Versus Rapid Atrial Pacing After Catheter Ablation of Paroxysmal Atrial Fibrillation

Evidence for Longitudinal and Transverse Fiber Conduction in Human Pulmonary Veins

ViewFlex Xtra ICE Catheter. Positioning Reference Manual

Key words: Paroxysmal atrial fibrillation, Pulmonary vein isolation, Cardiac autonomic nerve denervation, Catheter ablation

Jesus M. Paylos, C. Ferrero, L. Azcona, A. Morales, M. A. Vargas, L. Lacal, V. Gomez Tello.

Reentry in a Pulmonary Vein as a Possible Mechanism of Focal Atrial Fibrillation

480 April 2004 PACE, Vol. 27

AF and arrhythmia management. Dr Rhys Beynon Consultant Cardiologist and Electrophysiologist University Hospital of North Staffordshire

Combined catheter ablation and left atrial appendage closure as a. treatment of atrial fibrillation

How to Distinguish Focal Atrial Tachycardia from Small Circuits and Reentry

Catheter-Induced Linear Lesions in the Left Atrium in Patients With Atrial Fibrillation An Electroanatomic Study

SEVEN YEARS OF CRYO-BALLOON CATHETER ABLATION

Ankara, Turkey 2 Department of Cardiology, Division of Arrhythmia and Electrophysiology, Yuksek Ihtisas

In Whom and When Should Atrial Fibrillation Ablation be Considered?

Electrical and Mechanical Insights of Human Atrial Fibrillation. Sághy László, MD. Summary of PhD Thesis

Transcription:

Optimal approach to the ablation of PAF: Importance of identifying triggers David J. Callans, MD University of Pennsylvania School of Medicine AF ablation Penn experience Antral (circumferential) PV ablation Ablation guided by -- Multipolar circular catheter recording -- three dimensional mapping -- intracardiac echocardiography PV triggers provoked (pre/post) and non-pv triggers mapped; importance of high dose isoproterenol Not built for speed but safety and to study what subsequent approaches may be helpful Substrate ablation: potential mechanism(s) 1. reduction in functional atrial size 2. pulmonary vein isolation or change in conduction of triggers (? affecting ability to induce AF) 3. elimination of anchor points for rotors in the posterior venous atrium 4. ablation of the ligament of Marshall 5. autonomic denervation Haissaguerre M: NEJM 1998 Pappone C: Circulation 2001 1

Substrate ablation vs. PV isolation Freedom from symptomatic PAF off AAD: 89 vs 67% Oral H: Circulation 2003 Identification of PV ostia with ICE LSPV LIPV 2

Provoking triggers for AF initiation Stimulation to exclude accessory pathway/ AVNRT Initiation of triggers in patients with infrequent / absent spontaneous triggers - 93% of patients Isoproterenol (6-20mcg/min dose guided by trigger onset/side effects most tolerate average 12 mcg/min) triggers provoked in 79% A fib initiation with rapid pacing during low dose isoproterenol (1-3ug) infusion followed by CV triggers provoked in additional 14% Even more important as test of cure post RF Non pulmonary vein triggers of AF AVNRT 16 Left atrial posterior wall 11 Crista Terminalis 9 Eustacian Ridge/ CS Os region Mitral Valve Annulus 5 Superior Vena Cava 4 Fossa Ovalis/Limbus 4 Para-Hisian 3 Right Atrial Appendage 3 Tricuspid Valve Annulus 2 Ligament of Marshall 1 8 Sinus I avf V1 Lasso1 LA tachycardia from medial mitral annulus triggering RSPV AF trigger Lasso 10 Abld Ablp CSd CSp CRd SVC trigger CRp 3

AF caused by AVNRT (diagnosed in lab) Influence of AF type on Non PV triggers I V1 Total 761 pts Paroxysmal 440 pts (58%) Persistent 282 pts (37%) Persist > 1 yr 39 pts (5%) HBEp HBEd CS p CS d CT d AF Observed in 4.3% (new diagnosis) 13/27, AVNRT was the only trigger 12/13 no AF after slow pathway modification alone Any Non PV trigger 113 pts (15%) 72 (16%) 39 (14%) 2(6%) AT 89pts (12%) 53 (12%) 35 ( 12%) 1 ( 3%) CT p RVA AVNRT or AVRT 28 pts (4%) 21 (5%) 6 (2%) 1 (3%) Acute PV reconnection 30 minutes after isolation 153/290 pts (52.8%) and 231/856 PVs (27.0%) Baseline Lasso in LSPV AF Initiation Immediate post RF LIPV Predictors of acute PV reconnection LSPV RIPV RSPV LA size persistent AF HTN sleep apnea age Reconnection after 20 min LSPV re-isolated 0 10 20 30 40 % Acute Reconnection Sauer et al Heart Rhythm 2006 4

RSPV isolated RSPV isolated 90 min Failure of PVI = reconnected PV Isoproterenol RSPV reisolated 74 patients (11 F, mean age 56) One or more segments reconnected in 1 previously ablated PV 97% Triggers from previously ablated PV: 77% Triggers from previously non-ablated PV: 15% Non-PV triggers 18% Left atrial flutter 5% Repeat PVI resulted in AF control in 86% Type of AF (paroxysmal / permanent) not a factor Callans DJ: JCE 2004 Advantages to less extensive ablation Less ablation likely to decrease risk of PV stenosis, collateral damage, thromboembolic complications Physiology of AF initiation is clear, AF maintenance is not Ablation lesions confined to PV LA junction may preserve posterior LA function (mechanical, endocrine) Lemola K: Heart Rhythm 2005 Verma A: JCE 2006 Macro-reentrant left atrial flutter rarely observed post PVI -- proarrhythmic effect of incomplete LA lines Jais P: Circulation 2004 Sanders P: Heart Rhythm 2004 5

LA flutter after wide area circumferential ablation Pappone, Circulation 2004: 10% Chugh/Morady, Heart Rhythm 2005: 24% Karch/Schmitt, Circulation 2005: 18% (cf. 2% with PV isolation) Haissaguerre M: JCE 2005 Takahashi Y: JACC 2007 mitral annular corridor focal Mesas, JACC 2004 Advantages to substrate ablation May be simpler to perform: single transseptal, shorter procedure duration, less fluoroscopy May addresses other possible mechanisms in addition to initiation of AF by PV triggers Effect of ablation? not as susceptible to Achilles heal of PV isolation: reconnection May be more effective in established AF Reporting Outcome LACA vs SOA F/U = 6 mos Repeat Procedures 0% 33% Blanking Period Number on Drugs Monitoring Techniques Number of Repeat Procedures LACA vs CONTROL F/U = 12 mos Oral H et al: Circulation 2003 Oral H et al: NEJM 2006 % of patients without AF PV Antral Isolation and Non PV triggers 100 80 60 40 20 0 20± 9 months (6-60 months) N = 366pts Gentlesk et al: JCE 2006 28% 6

Penn Experience - PV Isolation plus elimination of non PV triggers (902 pts, > 1 year follow up) 100 80 60 40 20 0 87% 10% 12% 65% 90% 9% 11% 70% 81% 12% 13% 56% Overall PAF Persist/Perm 30 +/- 18 mos 30 +/- 19 mos 28 +/- 16 mos (Range 12-97 mos) (Range 12-97 mos) (Range 12-97 mos) N=902 N=604 N=298 AF Control on Restarted AAD AF Control on AAD-never stopped No AF off AAD Repeat Procedure: 23%=PAF, 31% Persistent (26% > 1 yr) PVI + trigger ablation for paroxysmal AF My opinions -- 1. PV isolation is a necessary part of any ablation strategy 2. The effect of extensive ablation on LA function is not completely clear, but is probably not beneficial 3. Recurrent AF after ablation is virtually always due to PV reconnection 4. Non PV triggers can cause AF. Failure to consider them probably means failure 7